SPDR S&P Biotech is an open-end investment management company. The Fund seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. As of June 30 2015, the Fund's total assets and investment porfolio totaled $3,360,344,396 and $3,327,690,681, respectively. We show 215 historical shares outstanding datapoints in our coverage of XBI's shares outstanding history.
Understanding the changing numbers of XBI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like XBI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching XBI by allowing them to research XBI shares outstanding history
as well as any other stock in our coverage universe. |
Free XBI Email Alerts:
Video: Shares Outstanding Importance
